Letters to the EditorsCOVID-19 Vaccine–Associated Takotsubo CardiomyopathyJani, Chinmay1,2; Leavitt, Jeffrey1,2,3; Al Omari, Omar1,2; Dimaso, Alana1,2; Pond, Kyle1,2,3; Gannon, Stephen1,2,3; Chandran, Arun Kumar1,2,3; Dennis, Christopher1,2; Colgrove, Robert1,2,4 Author Information 1Department of Internal Medicine, Mount Auburn Hospital, Beth Israel Lahey Health, Cambridge, MA 2Harvard Medical School, Boston, MA 3Division of Cardiology, Mount Auburn Hospital, Beth Israel Lahey Health, Cambridge, MA 4Division of Infectious Disease, Mount Auburn Hospital, Beth Israel Lahey Health, Cambridge, MA The authors have no conflicts of interest to declare. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.americantherapeutics.com). Each of the authors significantly contributed to this article. Dr C. Jani, Dr J. Leavitt, Dr C. Dennis, and Dr R. Colgrove made significant contribution to the concept and design of this article. Dr C. Jani, Dr O. Al Omari, Dr A. Dimaso, Dr S. Gannon, Dr K. Pond, Dr J. Leavitt, Dr A. K. Chandran, Dr C. Dennis, and Dr R. Colgrove were greatly involved in drafting article. Dr J. Leavitt, Dr C. Dennis, and Dr R. Colgrove were involved in critical revision of the article and contributed vital intellectual content. All authors are responsible for the contents and have read and approved the article for submission. Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request. American Journal of Therapeutics: May/June 2021 - Volume 28 - Issue 3 - p 361-364 doi: 10.1097/MJT.0000000000001379 Buy SDC Metrics Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.